Article Information
History
- February 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marco Barreca1,2,
- Matteo Dugo3,
- Barbara Galbardi3,
- Balázs Győrffy4,5,6,
- NA-PHER2 consortium,
- NeoTRIP consortium,
- Pinuccia Valagussa2,
- Daniela Besozzi7,8,
- Giuseppe Viale9,
- Giampaolo Bianchini3,10,
- Luca Gianni2 and
- Maurizio Callari2,*
- 1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy
- 2Michelangelo Foundation, Milan, Italy
- 3IRCCS San Raffaele Hospital, Milan, Italy
- 4Department of Bioinformatics, Semmelweis University, H-1094, Budapest, Hungary
- 5Department of Biophysics, Medical School, University of Pecs, H-7624, Pecs, Hungary
- 6Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Research Centre for Natural Sciences, H-1117, Budapest, Hungary
- 7Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy
- 8Bicocca Bioinformatics, Biostatistics and Bioimaging (B4) Research Centre, Milan, Italy
- 9European Institute of Oncology, Milan, Italy
- 10UniSR San Raffaele University, Milan, Italy
- ↵*Corresponding author: maurizio.callari{at}fondazionemichelangelo.org
Posted February 27, 2024.
Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer
